Delivery Order SPE2DR25D3016-SPE2DR26FG3WL
Award Date 1/28/26
Potential Completion Date 2/19/26
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $20,978.80 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 10, 2026, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,328.12 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count packages) with a firm fixed-price structure and delivery to Conshohocken, Pennsylvania. This non-set-aside competitive award was issued on January 27, 2026, with an ultimate completion date of February 18, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a subsidiary of Cencora, Inc....
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Imbruvica 140 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,983.68 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) on November 12, 2025, with completion targeted for December 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,328.12 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count) with a firm fixed-price structure and completion deadline of February 2, 2026. This non-set-aside award was competitively procured and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December...
- The Defense Logistics Agency awarded a $41,831.16 delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Imbruvica 280 mg tablets (quantity 28). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with final delivery required by February 11, 2026. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. The award is issued as a child...
- The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). This non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $7,983.68 delivery order to AmerisourceBergen Drug Corp for 420 mg Imbruvica tablets (quantity: 28 units) on November 20, 2025, with completion scheduled for December 12, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $23,951.04 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 280 mg tablets (28-count units) with a completion date of January 21, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and...